Pontocerebellar hypoplasia type 6 caused by mutations in RARS2

Definition of the clinical spectrum and molecular findings in five patients

Denise Cassandrini, Maria Roberta Cilio, Marzia Bianchi, Mara Doimo, Martina Balestri, Alessandra Tessa, Teresa Rizza, Geppo Sartori, Maria Chiara Meschini, Claudia Nesti, Giulia Tozzi, Vittoria Petruzzella, Fiorella Piemonte, Luigi Bisceglia, Claudio Bruno, Carlo Dionisi-Vici, Adele D'Amico, Fabiana Fattori, Rosalba Carrozzo, Leonardo Salviati & 2 others Filippo M. Santorelli, Enrico Bertini

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Recessive mutations in the mitochondrial arginyl-transfer RNA synthetase (RARS2) gene have been associated with early onset encephalopathy with signs of oxidative phosphorylation defects classified as pontocerebellar hypoplasia 6. We describe clinical, neuroimaging and molecular features on five patients from three unrelated families who displayed mutations in RARS2. All patients rapidly developed a neonatal or early-infantile epileptic encephalopathy with intractable seizures. The long-term follow-up revealed a virtual absence of psychomotor development, progressive microcephaly, and feeding difficulties. Mitochondrial respiratory chain enzymes in muscle and fibroblasts were normal in two. Blood and CSF lactate was abnormally elevated in all five patients at early stages while appearing only occasionally abnormal with the progression of the disease. Cerebellar vermis hypoplasia with normal aspect of the cerebral and cerebellar hemispheres appeared within the first months of life at brain MRI. In three patients follow-up neuroimaging revealed a progressive pontocerebellar and cerebral cortical atrophy. Molecular investigations of RARS2 disclosed the c.25A>G/p.I9V and the c.1586+3A>T in family A, the c.734G>A/p.R245Q and the c.1406G>A/p.R469H in family B, and the c.721T>A/p.W241R and c.35A>G/p.Q12R in family C. Functional complementation studies in Saccharomyces cerevisiae showed that mutation MSR1-R531H (equivalent to human p.R469H) abolished respiration whereas the MSR1-R306Q strain (corresponding to p.R245Q) displayed a reduced growth on non-fermentable YPG medium. Although mutations functionally disrupted yeast we found a relatively well preserved arginine aminoacylation of mitochondrial tRNA. Clinical and neuroimaging findings are important clues to raise suspicion and to reach diagnostic accuracy for RARS2 mutations considering that biochemical abnormalities may be absent in muscle biopsy.

Original languageEnglish
Pages (from-to)43-53
Number of pages11
JournalJournal of Inherited Metabolic Disease
Volume36
Issue number1
DOIs
Publication statusPublished - Jan 2013

Fingerprint

Mutation
Neuroimaging
Brain Diseases
Transfer RNA Aminoacylation
Amino Acyl-tRNA Synthetases
Muscles
Microcephaly
Oxidative Phosphorylation
Cerebrum
Electron Transport
Atrophy
Saccharomyces cerevisiae
Arginine
Disease Progression
Lactic Acid
Respiration
Seizures
Fibroblasts
Yeasts
Pontocerebellar Hypoplasia Type 6

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Pontocerebellar hypoplasia type 6 caused by mutations in RARS2 : Definition of the clinical spectrum and molecular findings in five patients. / Cassandrini, Denise; Cilio, Maria Roberta; Bianchi, Marzia; Doimo, Mara; Balestri, Martina; Tessa, Alessandra; Rizza, Teresa; Sartori, Geppo; Meschini, Maria Chiara; Nesti, Claudia; Tozzi, Giulia; Petruzzella, Vittoria; Piemonte, Fiorella; Bisceglia, Luigi; Bruno, Claudio; Dionisi-Vici, Carlo; D'Amico, Adele; Fattori, Fabiana; Carrozzo, Rosalba; Salviati, Leonardo; Santorelli, Filippo M.; Bertini, Enrico.

In: Journal of Inherited Metabolic Disease, Vol. 36, No. 1, 01.2013, p. 43-53.

Research output: Contribution to journalArticle

@article{b1441081fb8b45eab96edc3330d4fb88,
title = "Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: Definition of the clinical spectrum and molecular findings in five patients",
abstract = "Recessive mutations in the mitochondrial arginyl-transfer RNA synthetase (RARS2) gene have been associated with early onset encephalopathy with signs of oxidative phosphorylation defects classified as pontocerebellar hypoplasia 6. We describe clinical, neuroimaging and molecular features on five patients from three unrelated families who displayed mutations in RARS2. All patients rapidly developed a neonatal or early-infantile epileptic encephalopathy with intractable seizures. The long-term follow-up revealed a virtual absence of psychomotor development, progressive microcephaly, and feeding difficulties. Mitochondrial respiratory chain enzymes in muscle and fibroblasts were normal in two. Blood and CSF lactate was abnormally elevated in all five patients at early stages while appearing only occasionally abnormal with the progression of the disease. Cerebellar vermis hypoplasia with normal aspect of the cerebral and cerebellar hemispheres appeared within the first months of life at brain MRI. In three patients follow-up neuroimaging revealed a progressive pontocerebellar and cerebral cortical atrophy. Molecular investigations of RARS2 disclosed the c.25A>G/p.I9V and the c.1586+3A>T in family A, the c.734G>A/p.R245Q and the c.1406G>A/p.R469H in family B, and the c.721T>A/p.W241R and c.35A>G/p.Q12R in family C. Functional complementation studies in Saccharomyces cerevisiae showed that mutation MSR1-R531H (equivalent to human p.R469H) abolished respiration whereas the MSR1-R306Q strain (corresponding to p.R245Q) displayed a reduced growth on non-fermentable YPG medium. Although mutations functionally disrupted yeast we found a relatively well preserved arginine aminoacylation of mitochondrial tRNA. Clinical and neuroimaging findings are important clues to raise suspicion and to reach diagnostic accuracy for RARS2 mutations considering that biochemical abnormalities may be absent in muscle biopsy.",
author = "Denise Cassandrini and Cilio, {Maria Roberta} and Marzia Bianchi and Mara Doimo and Martina Balestri and Alessandra Tessa and Teresa Rizza and Geppo Sartori and Meschini, {Maria Chiara} and Claudia Nesti and Giulia Tozzi and Vittoria Petruzzella and Fiorella Piemonte and Luigi Bisceglia and Claudio Bruno and Carlo Dionisi-Vici and Adele D'Amico and Fabiana Fattori and Rosalba Carrozzo and Leonardo Salviati and Santorelli, {Filippo M.} and Enrico Bertini",
year = "2013",
month = "1",
doi = "10.1007/s10545-012-9487-9",
language = "English",
volume = "36",
pages = "43--53",
journal = "Journal of Inherited Metabolic Disease",
issn = "0141-8955",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Pontocerebellar hypoplasia type 6 caused by mutations in RARS2

T2 - Definition of the clinical spectrum and molecular findings in five patients

AU - Cassandrini, Denise

AU - Cilio, Maria Roberta

AU - Bianchi, Marzia

AU - Doimo, Mara

AU - Balestri, Martina

AU - Tessa, Alessandra

AU - Rizza, Teresa

AU - Sartori, Geppo

AU - Meschini, Maria Chiara

AU - Nesti, Claudia

AU - Tozzi, Giulia

AU - Petruzzella, Vittoria

AU - Piemonte, Fiorella

AU - Bisceglia, Luigi

AU - Bruno, Claudio

AU - Dionisi-Vici, Carlo

AU - D'Amico, Adele

AU - Fattori, Fabiana

AU - Carrozzo, Rosalba

AU - Salviati, Leonardo

AU - Santorelli, Filippo M.

AU - Bertini, Enrico

PY - 2013/1

Y1 - 2013/1

N2 - Recessive mutations in the mitochondrial arginyl-transfer RNA synthetase (RARS2) gene have been associated with early onset encephalopathy with signs of oxidative phosphorylation defects classified as pontocerebellar hypoplasia 6. We describe clinical, neuroimaging and molecular features on five patients from three unrelated families who displayed mutations in RARS2. All patients rapidly developed a neonatal or early-infantile epileptic encephalopathy with intractable seizures. The long-term follow-up revealed a virtual absence of psychomotor development, progressive microcephaly, and feeding difficulties. Mitochondrial respiratory chain enzymes in muscle and fibroblasts were normal in two. Blood and CSF lactate was abnormally elevated in all five patients at early stages while appearing only occasionally abnormal with the progression of the disease. Cerebellar vermis hypoplasia with normal aspect of the cerebral and cerebellar hemispheres appeared within the first months of life at brain MRI. In three patients follow-up neuroimaging revealed a progressive pontocerebellar and cerebral cortical atrophy. Molecular investigations of RARS2 disclosed the c.25A>G/p.I9V and the c.1586+3A>T in family A, the c.734G>A/p.R245Q and the c.1406G>A/p.R469H in family B, and the c.721T>A/p.W241R and c.35A>G/p.Q12R in family C. Functional complementation studies in Saccharomyces cerevisiae showed that mutation MSR1-R531H (equivalent to human p.R469H) abolished respiration whereas the MSR1-R306Q strain (corresponding to p.R245Q) displayed a reduced growth on non-fermentable YPG medium. Although mutations functionally disrupted yeast we found a relatively well preserved arginine aminoacylation of mitochondrial tRNA. Clinical and neuroimaging findings are important clues to raise suspicion and to reach diagnostic accuracy for RARS2 mutations considering that biochemical abnormalities may be absent in muscle biopsy.

AB - Recessive mutations in the mitochondrial arginyl-transfer RNA synthetase (RARS2) gene have been associated with early onset encephalopathy with signs of oxidative phosphorylation defects classified as pontocerebellar hypoplasia 6. We describe clinical, neuroimaging and molecular features on five patients from three unrelated families who displayed mutations in RARS2. All patients rapidly developed a neonatal or early-infantile epileptic encephalopathy with intractable seizures. The long-term follow-up revealed a virtual absence of psychomotor development, progressive microcephaly, and feeding difficulties. Mitochondrial respiratory chain enzymes in muscle and fibroblasts were normal in two. Blood and CSF lactate was abnormally elevated in all five patients at early stages while appearing only occasionally abnormal with the progression of the disease. Cerebellar vermis hypoplasia with normal aspect of the cerebral and cerebellar hemispheres appeared within the first months of life at brain MRI. In three patients follow-up neuroimaging revealed a progressive pontocerebellar and cerebral cortical atrophy. Molecular investigations of RARS2 disclosed the c.25A>G/p.I9V and the c.1586+3A>T in family A, the c.734G>A/p.R245Q and the c.1406G>A/p.R469H in family B, and the c.721T>A/p.W241R and c.35A>G/p.Q12R in family C. Functional complementation studies in Saccharomyces cerevisiae showed that mutation MSR1-R531H (equivalent to human p.R469H) abolished respiration whereas the MSR1-R306Q strain (corresponding to p.R245Q) displayed a reduced growth on non-fermentable YPG medium. Although mutations functionally disrupted yeast we found a relatively well preserved arginine aminoacylation of mitochondrial tRNA. Clinical and neuroimaging findings are important clues to raise suspicion and to reach diagnostic accuracy for RARS2 mutations considering that biochemical abnormalities may be absent in muscle biopsy.

UR - http://www.scopus.com/inward/record.url?scp=84872609485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872609485&partnerID=8YFLogxK

U2 - 10.1007/s10545-012-9487-9

DO - 10.1007/s10545-012-9487-9

M3 - Article

VL - 36

SP - 43

EP - 53

JO - Journal of Inherited Metabolic Disease

JF - Journal of Inherited Metabolic Disease

SN - 0141-8955

IS - 1

ER -